Mitchell, Daniel Anthony, Ilyas, Rebecca, Dodds, Alister W. and Sim, Robert B.. (2008) Enzyme-independent, orientation-selective conjugation of whole human complement C3 to protein surfaces. Journal of Immunological Methods, Vol.337 (No.1). pp. 49-54. ISSN 0022-1759

Full text not available from this repository.

Abstract

Complement C3 is a central component of the humoral immune system. Upon triggering of the complement cascade, proteolytic fragments of C3 mediate important processes such as opsonization and lymphocyte activation. C3 possesses an internal thioester that mediates covalent attachment of proteolytically activated C3 to target surfaces. Treatment of native C3 with methylamine cleaves the thioester bond and exposes a free sulfhydryl group at the target-binding face of the protein. Through the use of sulfhydryl-reactive heterobifunctional Crosslinking and biotinylation reagents, we demonstrate the capacity to form stable, multimeric whole human C3-protein conjugates in a fashion reflecting the orientation of physiologically-activated C3. We speculate that this C3 conjugation strategy presents a route for targeting dendritic cells and macrophages. In addition, manipulation of the thioester bond could enhance the study of biological roles of C3 and related proteins such as C4, and also of transmissible agents that exploit complement function such as prions. (C) 2008 Elsevier B.V. All rights reserved.

Item Type:	Journal Article
Subjects:	Q Science > QD Chemistry Q Science > QR Microbiology > QR180 Immunology
Divisions:	Faculty of Medicine > Warwick Medical School > Metabolic and Vascular Health Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Complement (Immunology), Immunological adjuvants, Biochemistry
Journal or Publication Title:	Journal of Immunological Methods
Publisher:	Elsevier BV
ISSN:	0022-1759
Date:	20 August 2008
Volume:	Vol.337
Number:	No.1
Number of Pages:	6
Page Range:	pp. 49-54
Identification Number:	10.1016/j.jim.2008.05.011
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Funder:	European Union (EU), University of Warwick
Grant number:	FOOD-CT-2006-023144 (EU)
References:	Altman, J.D., Moss, P.A., Goulder, P.J., Barouch, D.H., McHeyzer-Williams, M.G., Bell, J.I., McMichael, A.J., Davis, M.M., 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94. Arnaout, M.A., Dana, N., Melamed, J., Medicus, R., Colten, H.R., 1983. Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunology 48, 229. Behrens, E.M., Sriram, U., Shivers, D.K., Gallucci, M., Ma, Z., Finkel, T.H., Gallucci, S., 2007. Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. J. Immunol. 178, 6268. Blanquet-Grossard, F., Thielens, N.M., Vendrely, C., Jamin, M., Arlaud, G.J., 2005. Complement protein C1q recognizes a conformationally modified form of the prion protein. Biochemistry 44, 4349. Chen, C.B., Wallis, R., 2004. Two mechanisms for mannose-binding protein modulation of the activity of its associated serine proteases. J. Biol. Chem. 279, 26058. Cretin, F.C., Serra, V.A., Villiers, M.B., Laharie, A.M., Marche, P.N., Gabert, F.M., 2007. C3b complexation diversifies naturally processed T cell epitopes. Mol. Immunol. 44, 2893. Dempsey, P.W., Allison, M.E., Akkaraju, S., Goodnow, C.C., Fearon, D.T., 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348. Dodds, A.W., 1993. Small-scale preparation of complement components C3 and C4. Methods Enzymol. 223, 46. Flinn, N.S., Quibell, M., Turnell, W.G., Monk, T.P., Ramjee, M.K., 2004. Novel chemoselective linkage chemistry toward controlled loading of ligands to proteins through in situ real-time quantification of conjugate formation. Bioconjug. Chem. 15, 1010. Gadjeva, M., Dodds, A.W., Taniguchi-Sidle, A., Willis, A.C., Isenman, D.E., Law, S.K., 1998. The covalent binding reaction of complement component C3. J. Immunol. 161, 985. Holers, V.M., 2000. Phenotypes of complement knockouts. Immunopharmacology 49, 125. Howard, J.B., 1980. Methylamine reaction and denaturation-dependent fragmentation of complement component 3. Comparison with alpha2- macroglobulin. J. Biol. Chem. 255, 7082. Isenman, D.E., Kells, D.I., Cooper, N.R., Muller-Eberhard, H.J., Pangburn, M.K., 1981. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry 20, 4458. Janssen, B.J., Christodoulidou, A., McCarthy, A., Lambris, J.D., Gros, P., 2006. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444, 213. Janssen, B.J., Huizinga, E.G., Raaijmakers, H.C., Roos, A., Daha, M.R., Nilsson- Ekdahl, K., Nilsson, B., Gros, P., 2005. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505. Klein, M.A., Kaeser, P.S., Schwarz, P., Weyd, H., Xenarios, I., Zinkernagel, R.M., Carroll, M.C., Verbeek, J.S., Botto, M.,Walport, M.J., Molina, H., Kalinke, U., Acha-Orbea, H., Aguzzi, A., 2001. Complement facilitates early prion pathogenesis. Nat. Med. 7, 488. Mabbott, N.A., Bruce, M.E., Botto, M., Walport, M.J., Pepys, M.B., 2001. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat. Med. 7, 485. Micklem, K.J., Sim, R.B., 1985. Isolation of complement-fragment-iC3bbinding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein. Biochem. J. 231, 233. Mitchell, D.A., Kirby, L., Paulin, S.M., Villiers, C.L., Sim, R.B., 2007. Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue. Mol. Immunol. 44, 2997. Parkes, C., DiScipio, R.G., Kerr, M.A., Prohaska, R., 1981. The separation of functionally distinct forms of the third component of human complement (C3). Biochem. J. 193, 963. Pickering, M.C., Cook, H.T., Warren, J., Bygrave, A.E., Moss, J., Walport, M.J., Botto, M., 2002. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 31, 424. Rozis, G., de Silva, S., Benlahrech, A., Papagatsias, T., Harris, J., Gotch, F., Dickson, G., Patterson, S., 2005. Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: implications for mucosal vaccines. Eur. J. Immunol. 35, 2617. Seya, T., Holers, V.M., Atkinson, J.P., 1985. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF). J. Immunol. 135, 2661. Sim, R.B., Sim, E., 1981. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2- macroglobulin. Biochem. J. 193, 129. Ueda, T., Rieu, P., Brayer, J., Arnaout, M.A., 1994. Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/ CD18). Proc. Natl. Acad. Sci. U. S. A. 91, 10680. Villiers, M.B., Villiers, C.L., Laharie, A.M., Marche, P.N., 1999. Amplification of the antibody response by C3b complexed to antigen through an ester link. J. Immunol. 162, 3647. Walport, M.J., 2001a. Complement. First of two parts. N. Engl. J. Med. 344, 1058. Walport, M.J., 2001b. Complement. Second of two parts. N. Engl. J. Med. 344, 1140. Zabel, M.D., Weis, J.H., 2001. Cell-specific regulation of the CD21 gene. Int. Immunopharmacol. 1, 483.
URI:	http://wrap.warwick.ac.uk/id/eprint/29505

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item